Legal & General Group PLC Summit Therapeutics Inc. Transaction History
Legal & General Group PLC
- $440 Billion
- Q2 2024
A detailed history of Legal & General Group PLC transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 28,233 shares of SMMT stock, worth $567,483. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,233
Previous 117,618
76.0%
Holding current value
$567,483
Previous $486,000
54.73%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding SMMT
# of Institutions
138Shares Held
64.4MCall Options Held
1.06MPut Options Held
1.02M-
Baker Bros. Advisors LP New York, NY23.2MShares$467 Million2.41% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.82MShares$177 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$159 Million0.0% of portfolio
-
State Street Corp Boston, MA4.12MShares$82.9 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.96MShares$59.6 Million0.0% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $4.04B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...